98 related articles for article (PubMed ID: 23942039)
1. Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass.
Bristow RE; Hodeib M; Smith A; Chan DW; Zhang Z; Fung ET; Tewari KS; Munroe DG; Ueland FR
Am J Obstet Gynecol; 2013 Dec; 209(6):581.e1-8. PubMed ID: 23942039
[TBL] [Abstract][Full Text] [Related]
2. Clinical performance of a multivariate index assay for detecting early-stage ovarian cancer.
Longoria TC; Ueland FR; Zhang Z; Chan DW; Smith A; Fung ET; Munroe DG; Bristow RE
Am J Obstet Gynecol; 2014 Jan; 210(1):78.e1-9. PubMed ID: 24055582
[TBL] [Abstract][Full Text] [Related]
3. Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass.
Havrilesky LJ; Dinan M; Sfakianos GP; Curtis LH; Barnett JC; Van Gorp T; Myers ER
J Natl Cancer Inst; 2015 Jan; 107(1):322. PubMed ID: 25515232
[TBL] [Abstract][Full Text] [Related]
4. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
Bristow RE; Smith A; Zhang Z; Chan DW; Crutcher G; Fung ET; Munroe DG
Gynecol Oncol; 2013 Feb; 128(2):252-9. PubMed ID: 23178277
[TBL] [Abstract][Full Text] [Related]
5. Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
Coleman RL; Herzog TJ; Chan DW; Munroe DG; Pappas TC; Smith A; Zhang Z; Wolf J
Am J Obstet Gynecol; 2016 Jul; 215(1):82.e1-82.e11. PubMed ID: 26970494
[TBL] [Abstract][Full Text] [Related]
6. Applicability of the modified ACOG/SGO referral criteria for adnexal mass within a limited-resource setting.
Battarbee A; Strohl A; Zimmerman L; Patel A; Burtch R
Int J Gynaecol Obstet; 2017 Jan; 136(1):53-57. PubMed ID: 28099697
[TBL] [Abstract][Full Text] [Related]
7. How relevant are ACOG and SGO guidelines for referral of adnexal mass?
Dearking AC; Aletti GD; McGree ME; Weaver AL; Sommerfield MK; Cliby WA
Obstet Gynecol; 2007 Oct; 110(4):841-8. PubMed ID: 17906018
[TBL] [Abstract][Full Text] [Related]
8. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.
Miller RW; Smith A; DeSimone CP; Seamon L; Goodrich S; Podzielinski I; Sokoll L; van Nagell JR; Zhang Z; Ueland FR
Obstet Gynecol; 2011 Jun; 117(6):1298-1306. PubMed ID: 21555961
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of a multivariate index assay compared to modified American College of Obstetricians and Gynecologists criteria and CA-125 in the triage of women with adnexal masses.
Forde GK; Hornberger J; Michalopoulos S; Bristow RE
Curr Med Res Opin; 2016; 32(2):321-9. PubMed ID: 26588255
[TBL] [Abstract][Full Text] [Related]
10. Low-risk multivariate index assay scores, physician referral and surgical choices in women with adnexal masses.
Dunton CJ; Eskander RN; Bullock RG; Pappas T
Curr Med Res Opin; 2020 Dec; 36(12):2079-2083. PubMed ID: 33107342
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.
Ueland FR; Desimone CP; Seamon LG; Miller RA; Goodrich S; Podzielinski I; Sokoll L; Smith A; van Nagell JR; Zhang Z
Obstet Gynecol; 2011 Jun; 117(6):1289-1297. PubMed ID: 21606739
[TBL] [Abstract][Full Text] [Related]
12. Validation of referral guidelines for women with pelvic masses.
Im SS; Gordon AN; Buttin BM; Leath CA; Gostout BS; Shah C; Hatch KD; Wang J; Berman ML
Obstet Gynecol; 2005 Jan; 105(1):35-41. PubMed ID: 15625139
[TBL] [Abstract][Full Text] [Related]
13. Preoperative multimodal strategies for risk assessment of adnexal masses: analysis of 1362 cases in a gynecologic cancer center.
Radosa MP; Camara O; Vorwergk J; Diebolder H; Winzer H; Mothes A; Gajda M; Runnebaum IB
Int J Gynecol Cancer; 2011 Aug; 21(6):1056-62. PubMed ID: 21633301
[TBL] [Abstract][Full Text] [Related]
14. Ethnic disparity in clinical performance between multivariate index assay and CA125 in detection of ovarian malignancy.
Dunton C; Bullock RG; Fritsche H
Future Oncol; 2019 Sep; 15(26):3047-3051. PubMed ID: 31397588
[No Abstract] [Full Text] [Related]
15. Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses.
van den Akker PA; Aalders AL; Snijders MP; Kluivers KB; Samlal RA; Vollebergh JH; Massuger LF
Gynecol Oncol; 2010 Mar; 116(3):384-8. PubMed ID: 19959215
[TBL] [Abstract][Full Text] [Related]
16. The clinical utility of an elevated-risk multivariate index assay score in ovarian cancer patients.
Eskander RN; Carpenter BA; Wu HG; Wolf JK
Curr Med Res Opin; 2016 Jun; 32(6):1161-5. PubMed ID: 27052730
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of the preoperative platelet count in the diagnosis of adnexal tumors.
Watrowski R; Heinze G; Jäger C; Forster J; Zeillinger R
Tumour Biol; 2016 Sep; 37(9):12079-12087. PubMed ID: 27207344
[TBL] [Abstract][Full Text] [Related]
18. Impact of surgeon specialty on ovarian-conserving surgery in young females with an adnexal mass.
Bristow RE; Nugent AC; Zahurak ML; Khouzhami V; Fox HE
J Adolesc Health; 2006 Sep; 39(3):411-6. PubMed ID: 16919804
[TBL] [Abstract][Full Text] [Related]
19. Adnexal masses suspected to be benign treated with laparoscopy.
Demir RH; Marchand GJ
JSLS; 2012; 16(1):71-84. PubMed ID: 22906334
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Malignancy Probability Score (OMPS) for appropriate referral of adnexal masses.
Arab M; Honarvar Z; Hosseini-Zijoud SM
Asian Pac J Cancer Prev; 2014; 15(20):8647-50. PubMed ID: 25374183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]